<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Discovery Labs &#187; Uncategorized</title>
	<atom:link href="http://q-pharm.com/category/uncategorized/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Fri, 02 Mar 2012 06:38:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>MA/p17 HIV matrix protein is a promising target for drug discovery</title>
		<link>http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/</link>
		<comments>http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 14:00:43 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=385</guid>
		<description><![CDATA[As a result of the analysis of HIV virus targets, the most conservative among all the possible HIV-1 virus target protein—p17/MA (see figure)—was selected. This is a matrix (structural) protein,...
Related posts:<ol>
<li><a href='http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/' rel='bookmark' title='Influenza matrix M1 protein inhibitors show promising in-vivo efficacy'>Influenza matrix M1 protein inhibitors show promising in-vivo efficacy</a></li>
<li><a href='http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/' rel='bookmark' title='New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1'>New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/virtual-identification-of-a-protein-target/' rel='bookmark' title='Virtual Identification of a Protein Target'>Virtual Identification of a Protein Target</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2008 Quantum&#8217;s technology platform update and software releases</title>
		<link>http://q-pharm.com/2008/11/2008-quantums-technology-platform-update-and-software-releases/</link>
		<comments>http://q-pharm.com/2008/11/2008-quantums-technology-platform-update-and-software-releases/#comments</comments>
		<pubDate>Tue, 25 Nov 2008 11:26:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=45</guid>
		<description><![CDATA[It has been an exciting year here in Quantum Pharmaceuticals, another great year for our highly effective small molecule drug discovery and ADMET platform development. Our work is firmly based...
Related posts:<ol>
<li><a href='http://q-pharm.com/2008/12/video-recorded-from-water-as-a-ferroelectric-presentation-at-mipt-november-5th-2008/' rel='bookmark' title='Video recorded from &quot;Water as a ferroelectric&#8230;&quot; presentation at MIPT, November 5th, 2008'>Video recorded from &quot;Water as a ferroelectric&#8230;&quot; presentation at MIPT, November 5th, 2008</a></li>
<li><a href='http://q-pharm.com/2007/12/emd-serono-inc-licensed-quantum-pharmaceuticals%e2%80%99-drug-discovery-technology/' rel='bookmark' title='EMD Serono, Inc licensed Quantum’ drug discovery technology.'>EMD Serono, Inc licensed Quantum’ drug discovery technology.</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/11/2008-quantums-technology-platform-update-and-software-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantum Science Overview, v 0.1 has been released</title>
		<link>http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/</link>
		<comments>http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/#comments</comments>
		<pubDate>Tue, 18 Sep 2007 20:07:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=15</guid>
		<description><![CDATA[Quantum Pharmaceuticals is pleased to release Quantum Science Overview. The document conveys an overview Quantum&#8217;s drug discovery solutions and scientific results. The content of the report are summarized below:I. A...
Related posts:<ol>
<li><a href='http://q-pharm.com/2006/10/hiv-1-integrase-drug-discovery-collaboration/' rel='bookmark' title='HIV-1 integrase drug discovery collaboration'>HIV-1 integrase drug discovery collaboration</a></li>
<li><a href='http://q-pharm.com/2008/01/q-herg-quantums-innovative-approach-to-herg-binding-calculations-is-finally-released/' rel='bookmark' title='q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released'>q-hERG: QUANTUM&#8217;s innovative approach to hERG binding calculations is finally released</a></li>
<li><a href='http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/' rel='bookmark' title='From Biological Spectra (multiple protein binding data) to pharmacological profiling!'>From Biological Spectra (multiple protein binding data) to pharmacological profiling!</a></li>
<li><a href='http://q-pharm.com/2006/06/quantum-pharmaceuticals-and-institute-of-pulmonology-entered-copd-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.'>Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-and-albumin-binding-calculations-the-role-of-protein-flexibility/' rel='bookmark' title='QUANTUM and HSA binding calculations: the role of protein flexibility'>QUANTUM and HSA binding calculations: the role of protein flexibility</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular dynamics of HIV Integrase with an inhibitor</title>
		<link>http://q-pharm.com/2007/01/molecular-dynamics-of-hiv-integrase-with-an-inhibitor/</link>
		<comments>http://q-pharm.com/2007/01/molecular-dynamics-of-hiv-integrase-with-an-inhibitor/#comments</comments>
		<pubDate>Tue, 09 Jan 2007 09:15:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=8</guid>
		<description><![CDATA[Below we provide an example of Molecular Dynamics of HIV-integrase monomer with 1- (5- CHLOROINDOL-3- YL)-3 -HYDROXY-3 -(2H- TETRAZOL- 5- YL)-PROPENONE (pdb code 1qs4). The protein structure is taken from...
Related posts:<ol>
<li><a href='http://q-pharm.com/2009/04/molecular-polarization-on-a-polar-liquid-interface-the-structure-of-a-water-surface/' rel='bookmark' title='Molecular polarization on a polar liquid interface: the structure of a water surface'>Molecular polarization on a polar liquid interface: the structure of a water surface</a></li>
<li><a href='http://q-pharm.com/2006/10/hiv-1-integrase-drug-discovery-collaboration/' rel='bookmark' title='HIV-1 integrase drug discovery collaboration'>HIV-1 integrase drug discovery collaboration</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2007/01/molecular-dynamics-of-hiv-integrase-with-an-inhibitor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protein flexibilty and ligand interaction complementarity example</title>
		<link>http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/</link>
		<comments>http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/#comments</comments>
		<pubDate>Sun, 10 Dec 2006 18:19:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=7</guid>
		<description><![CDATA[Human neutrophil elastase complexed with an inhibitor (gw475151) studied with QUANTUM normal modes analysis tools. The video shows the inhibitor (red licorice) remains in a strongly interacting position regardless of...
Related posts:<ol>
<li><a href='http://q-pharm.com/2009/01/self-consistent-solvation-energy-contribution-calculation-for-protein-ligand-complexes/' rel='bookmark' title='Self-consistent solvation energy contribution calculation for protein-ligand complexes'>Self-consistent solvation energy contribution calculation for protein-ligand complexes</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-science-overview-v-0-1-has-been-released/' rel='bookmark' title='Quantum Science Overview, v 0.1 has been released'>Quantum Science Overview, v 0.1 has been released</a></li>
<li><a href='http://q-pharm.com/2007/05/quantum-free-energy-vs-statistical-scoring-functions/' rel='bookmark' title='QUANTUM free energy vs. statistical scoring functions'>QUANTUM free energy vs. statistical scoring functions</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2006/12/protein-flexibilty-and-ligand-interaction-complementarity-example/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

